Civic Intelligence

Kcnq2 Cure Alliance Inc.

990EZ • Fiscal year 2019 • EIN 47-1810644

Jan 01, 2019 to Dec 31, 2019 • Filed on Dec 01, 2020

3700 Northfield Quebec St Unit 100Denver, CO 80207

(303) 887-9532

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Liabilities / Revenue

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Net Margin

55th percentile

5.4%

Higher net margin than 55% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Top Officer Pay

77th percentile

$0

Higher top officer pay than 77% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Asset Growth

51st percentile

2.7%

Faster asset growth than 51% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Revenue Growth

61st percentile

8.7%

Faster revenue growth than 61% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Assets

Up

$373,686

Up $9,945 (+2.7%) from 2018

Net Assets

Up

$373,686

Up $9,945 (+2.7%) from 2018

Liabilities

Flat

$0

Flat from 2018

Revenue

Up

$182,915

Up $14,644 (+8.7%) from 2018

Expenses

Up

$172,970

Up $40,461 (+31%) from 2018

Net Income

Down

$9,945

Down $25,817 (-72%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2015: $48,786Liabilities 2015: $0Net Assets 2015: $48,7862015Assets 2016: $281,955Liabilities 2016: $0Net Assets 2016: $281,9552016Assets 2017: $300,383Liabilities 2017: $0Net Assets 2017: $300,3832017Assets 2018: $363,741Liabilities 2018: $0Net Assets 2018: $363,7412018Assets 2019: $373,686Liabilities 2019: $0Net Assets 2019: $373,6862019Assets 2020: $534,796Liabilities 2020: $0Net Assets 2020: $534,7962020Assets 2021: $601,426Liabilities 2021: $0Net Assets 2021: $601,4262021Assets 2022: $730,127Liabilities 2022: $0Net Assets 2022: $730,1272022Assets 2023: $881,712Liabilities 2023: $0Net Assets 2023: $881,7122023Assets 2024: $1,234,962Liabilities 2024: $11,319Net Assets 2024: $1,223,6432024

Highlighted filing

2019

Assets$373,686
Liabilities$0
Net Assets$373,686

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0Revenue 2015: $66,532Expenses 2015: $22,257Net Income 2015: $44,2752015Revenue 2016: $361,755Expenses 2016: $128,586Net Income 2016: $233,1692016Revenue 2017: $102,885Expenses 2017: $84,457Net Income 2017: $18,4282017Revenue 2018: $168,271Expenses 2018: $132,509Net Income 2018: $35,7622018Revenue 2019: $182,915Expenses 2019: $172,970Net Income 2019: $9,9452019Revenue 2020: $177,690Expenses 2020: $16,581Net Income 2020: $161,1092020Revenue 2021: $185,161Expenses 2021: $118,531Net Income 2021: $66,6302021Revenue 2022: $172,403Expenses 2022: $43,702Net Income 2022: $128,7012022Revenue 2023: $298,727Expenses 2023: $134,391Net Income 2023: $164,3362023Revenue 2024: $458,475Expenses 2024: $86,234Net Income 2024: $372,2412024

Highlighted filing

2019

Revenue$182,915
Expenses$172,970
Net Income$9,945
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Dec 1, 2020
Return Version
2019v5.0
Gross Receipts
$182,915
Mission and Program Overview

Mission

KCNQ2 Cure Alliance is a non-profit organization dedicated to raising research funds for KCNQ2 epileptic encephalophathy, a rate and catasrophic form of epilepsy. By offering research grants for KCNQ2 research with a novel approach, we can move researchers and the medical community forward to find better treatments and a cure while assisting afflicted individuals and their families.

Kcnq2 cure alliance is a non-profit organization dedicated to raising research funds for kcnq2 epileptic encephalopathy, a rare and catastrophic form of epilepsy. By offering research grants for kcnq2 research with a novel approach, we can move researchers and the medical community forward to find better treatments and a cure while assisting afflicted individuals and their families.

Program Services

DescriptionGrantsExpenses
IN COLLABORATION WITH BOSTON CHILDREN'S HOSPITAL THE GRANT FUNDED THE ACQUISITION AND CHARACTERISATION TO AN UPDATED KCNQ2 REGISTRY AND DRAFT NATURAL HISTORY STUDY OF 74 INTERNATIONAL PATIENTS. COUNTRIES THUS INVOLVED AND EXPANDED IN THE STUDY INCLUDE BULGARIA, CHINA, AUSTRALIA, CANADA, NORWAY, SPAIN, CROATIA, UNITED KINGDOM AND THE UNITED STATES. IN TOTAL 42 QUESTIONNAIRES WERE RETURNED AND ANALYZED FOR RELEVANT CLINICAL AND OVERALL SIGNIFICANCE RELEVANT TO FUTURE TRIAL STUDY. ADDITIONALLY, THE GRANT RESEARCH LEADS AT BCH ARE PREPARING A REPORT ON THE OVERALL STATISTICAL IMPACT OF BUILDING OUT A REGISTRY BACKED WITH PUBLISHED ARTICLES DETAILING THE IMPACT THE DATA HAS PROVIDED TO ASSIST WITH THE CREATION OF HUMAN CELL LINES, CRISPR WORK AND ADDITIONAL INPUT TO TRANSLATIONAL THERAPIES SUCH AS RNA AND OTHER GENE THERAPY APPROACHES.$150,255$160,221
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
JIM JOHNSONPresidentPT$0--
SARAH JAMES BUTCHERVice PresidePT$0--
CAROLINE LOEWYTreasurerPT$0--
SCOTTY SIMSSecretaryPT$0--
PATRICK ROBERTSBoard MemberPT$0--
Filing and Contact Details

Filer

Filer Name
Kcnq2 Cure Alliance
EIN
47-1810644
Phone
3038879532
Address
3700 NORTHFIELD QUEBEC ST UNIT 100, DENVER, CO 80207

Signing Officer

Name
Jim Johnson
Title
President
Phone
3038879532
Signed
2020-12-01
Discuss with paid preparer
Yes

Preparer

Firm
Taylor Roth and Company
Address
800 GRANT ST STE 205, DENVER, CO 80203-2944
Preparer
Diane K Granger
Phone
3038308109
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 10

Name: boston children's hospital address: 300 longwood avenue boston, ma 02115 cash contribution: 150,255

Form 990-ez, Part I, Line 16

Expenses bank fees 11,330 office supplies 17 business insurance/regis. 1,419 it & web development 3,457 audio/visual 240 travel and meetings 5,851 total 22,314

Form 990-ez, Part I, Line 20

Prior period adjustment 0

Form 990-ez, Part III

Kcnq2 cure alliance is a non-profit organization dedicated to raising research funds for kcnq2 epileptic encephalopathy, a rare and catastrophic form of epilepsy. By offering research grants for kcnq2 research with a novel approach, we can move researchers and the medical community forward to find better treatments and a cure while assisting afflicted individuals and their families.

Form 990-ez, Part III, Line 28

In collaboration with boston children's hospital the grant funded the acquisition and characterisation to an updated kcnq2 registry and draft natural history study of 74 international patients. Countries thus involved and expanded in the study include bulgaria, china, australia, canada, norway, spain, croatia, united kingdom and the united states. In total 42 questionnaires were returned and analyzed for relevant clinical and overall significance relevant to future trial study. Additionally, the grant research leads at bch are preparing a report on the overall statistical impact of building out a registry backed with published articles detailing the impact the data has provided to assist with the creation of human cell lines, crispr work and additional input to translational therapies such as rna and other gene therapy approaches.

Raw XML Appendix155 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0KCNQ2 CURE ALLIANCE
IRS990EZ/BooksInCareOfDetail/PhoneNum03038879532
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt03700 QUEBEC ST UNIT-100
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0DENVER
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CO
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd080207
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0363741
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0373686
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0162915
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt09945
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0363741
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0373686
IRS990EZ/GrantsAndSimilarAmountsPaidAmt0150255
IRS990EZ/GrossReceiptsAmt0182915
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0363741
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0373686
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0363741
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0373686
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt05.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt15.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt25.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt35.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt45.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0JIM JOHNSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1SARAH JAMES BUTCHER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2CAROLINE LOEWY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3SCOTTY SIMS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4PATRICK ROBERTS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE PRESIDE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SECRETARY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4BOARD MEMBER
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt022314
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0KCNQ2 CURE ALLIANCE IS A NON-PROFIT ORGANIZATION DEDICATED TO RAISING RESEARCH FUNDS FOR KCNQ2 EPILEPTIC ENCEPHALOPATHY, A RARE AND CATASTROPHIC FORM OF EPILEPSY. BY OFFERING RESEARCH GRANTS FOR KCNQ2 RESEARCH WITH A NOVEL APPROACH, WE CAN MOVE RESEARCHERS AND THE MEDICAL COMMUNITY FORWARD TO FIND BETTER TREATMENTS AND A CURE WHILE ASSISTING AFFLICTED INDIVIDUALS AND THEIR FAMILIES.
IRS990EZ/PrintingPublicationsPostageAmt0401
IRS990EZ/ProgramServiceRevenueAmt020000
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0IN COLLABORATION WITH BOSTON CHILDREN'S HOSPITAL THE GRANT FUNDED THE ACQUISITION AND CHARACTERISATION TO AN UPDATED KCNQ2 REGISTRY AND DRAFT NATURAL HISTORY STUDY OF 74 INTERNATIONAL PATIENTS. COUNTRIES THUS INVOLVED AND EXPANDED IN THE STUDY INCLUDE BULGARIA, CHINA, AUSTRALIA, CANADA, NORWAY, SPAIN, CROATIA, UNITED KINGDOM AND THE UNITED STATES. IN TOTAL 42 QUESTIONNAIRES WERE RETURNED AND ANALYZED FOR RELEVANT CLINICAL AND OVERALL SIGNIFICANCE RELEVANT TO FUTURE TRIAL STUDY. ADDITIONALLY, THE GRANT RESEARCH LEADS AT BCH ARE PREPARING A REPORT ON THE OVERALL STATISTICAL IMPACT OF BUILDING OUT A REGISTRY BACKED WITH PUBLISHED ARTICLES DETAILING THE IMPACT THE DATA HAS PROVIDED TO ASSIST WITH THE CREATION OF HUMAN CELL LINES, CRISPR WORK AND ADDITIONAL INPUT TO TRANSLATIONAL THERAPIES SUCH AS RNA AND OTHER GENE THERAPY APPROACHES.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ForeignGrantsInd0X
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt0150255
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0160221
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0172970
IRS990EZ/TotalProgramServiceExpensesAmt0160221
IRS990EZ/TotalRevenueAmt0182915
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.KCNQ2CURE.ORG
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0162915
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0161609
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt090308
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0355391
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt066513
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0836736
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0165
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0147
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0120
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt019
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0451
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt026497
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.83810
IRS990ScheduleA/PublicSupportTotal170Amt0701608
IRS990ScheduleA/SubstantialContributorsTotAmt0135128
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0162915
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0161609
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt090308
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0355391
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt066513
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0836736
IRS990ScheduleA/TotalSupportAmt0837187
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0NAME: BOSTON CHILDREN'S HOSPITAL ADDRESS: 300 LONGWOOD AVENUE BOSTON, MA 02115 CASH CONTRIBUTION: 150,255
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1EXPENSES BANK FEES 11,330 OFFICE SUPPLIES 17 BUSINESS INSURANCE/REGIS. 1,419 IT & WEB DEVELOPMENT 3,457 AUDIO/VISUAL 240 TRAVEL AND MEETINGS 5,851 TOTAL 22,314
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2PRIOR PERIOD ADJUSTMENT 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3KCNQ2 CURE ALLIANCE IS A NON-PROFIT ORGANIZATION DEDICATED TO RAISING RESEARCH FUNDS FOR KCNQ2 EPILEPTIC ENCEPHALOPATHY, A RARE AND CATASTROPHIC FORM OF EPILEPSY. BY OFFERING RESEARCH GRANTS FOR KCNQ2 RESEARCH WITH A NOVEL APPROACH, WE CAN MOVE RESEARCHERS AND THE MEDICAL COMMUNITY FORWARD TO FIND BETTER TREATMENTS AND A CURE WHILE ASSISTING AFFLICTED INDIVIDUALS AND THEIR FAMILIES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4IN COLLABORATION WITH BOSTON CHILDREN'S HOSPITAL THE GRANT FUNDED THE ACQUISITION AND CHARACTERISATION TO AN UPDATED KCNQ2 REGISTRY AND DRAFT NATURAL HISTORY STUDY OF 74 INTERNATIONAL PATIENTS. COUNTRIES THUS INVOLVED AND EXPANDED IN THE STUDY INCLUDE BULGARIA, CHINA, AUSTRALIA, CANADA, NORWAY, SPAIN, CROATIA, UNITED KINGDOM AND THE UNITED STATES. IN TOTAL 42 QUESTIONNAIRES WERE RETURNED AND ANALYZED FOR RELEVANT CLINICAL AND OVERALL SIGNIFICANCE RELEVANT TO FUTURE TRIAL STUDY. ADDITIONALLY, THE GRANT RESEARCH LEADS AT BCH ARE PREPARING A REPORT ON THE OVERALL STATISTICAL IMPACT OF BUILDING OUT A REGISTRY BACKED WITH PUBLISHED ARTICLES DETAILING THE IMPACT THE DATA HAS PROVIDED TO ASSIST WITH THE CREATION OF HUMAN CELL LINES, CRISPR WORK AND ADDITIONAL INPUT TO TRANSLATIONAL THERAPIES SUCH AS RNA AND OTHER GENE THERAPY APPROACHES.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART I, LINE 20
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02021-04-22 16:20:28Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0JIM JOHNSON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum03038879532
ReturnHeader/BusinessOfficerGrp/SignatureDt02020-12-01
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0KCNQ2 CURE ALLIANCE
ReturnHeader/Filer/BusinessNameControlTxt0KCNQ
ReturnHeader/Filer/EIN0471810644
ReturnHeader/Filer/PhoneNum03038879532
ReturnHeader/Filer/USAddress/AddressLine1Txt03700 NORTHFIELD QUEBEC ST UNIT 100
ReturnHeader/Filer/USAddress/CityNm0DENVER
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CO
ReturnHeader/Filer/USAddress/ZIPCd080207
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0F510452ABB4A09DEF72ED4AF0FBBE4EEFED67493
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0F510452ABB4A09DEF72ED4AF0FBBE4EEFED67493
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt024.128.123.73
ReturnHeader/FilingSecurityInformation/IPDt02020-12-02
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CS
ReturnHeader/FilingSecurityInformation/IPTm013:18:36
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0203746583
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0TAYLOR ROTH AND COMPANY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0800 GRANT ST STE 205
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0DENVER
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0802032944
ReturnHeader/PreparerPersonGrp/PhoneNum03038308109
ReturnHeader/PreparerPersonGrp/PreparationDt02020-12-02
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DIANE K GRANGER
ReturnHeader/ReturnTs02020-12-02T13:18:36-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02019-01-01
ReturnHeader/TaxPeriodEndDt02019-12-31
ReturnHeader/TaxYr02019

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2019 filings • 501(c)3 • <$500k nonprofits